![Howard Grossberg](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Howard Grossberg
Geen lopende functies
Loopbaan van Howard Grossberg
Eerdere bekende functies van Howard Grossberg
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
BioTransplant, Inc.
![]() BioTransplant, Inc. Pharmaceuticals: MajorHealth Technology BioTransplant, Inc. is a life science company. The company discovers, develops and commercializes therapeutics, therapeutic devices and therapeutic regimens designed to suppress undesired immune responses and enhance the body's ability to accept donor cells, tissues and organs. The company was founded on March 20, 1990 and is headquartered in Charlestown, MA. | Corporate Officer/Principal | - | - |
FOREST LABORATORIES, INC. | Hoofd Techniek/Wetenschap/O&O | - | - |
W WORL | Corporate Officer/Principal | 20-04-2005 | - |
Statistieken
Internationaal
Verenigde Staten | 4 |
Operationeel
Corporate Officer/Principal | 2 |
Chief Tech/Sci/R&D Officer | 1 |
Sectoraal
Health Technology | 4 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
W WORL | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
BioTransplant, Inc.
![]() BioTransplant, Inc. Pharmaceuticals: MajorHealth Technology BioTransplant, Inc. is a life science company. The company discovers, develops and commercializes therapeutics, therapeutic devices and therapeutic regimens designed to suppress undesired immune responses and enhance the body's ability to accept donor cells, tissues and organs. The company was founded on March 20, 1990 and is headquartered in Charlestown, MA. | Health Technology |
Forest Laboratories, Inc.
![]() Forest Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Forest Laboratories, Inc. is engaged in the development, manufacture, and sale of branded forms of drug products. Its products include Bystolic, which is used to decrease heart rate and myocardial contractility; Daliresp, which is used to reduce the risk of chronic obstructive pulmonary disease exacerbation; Linzess, which is used in the treatment of irritable bowel syndrome with constipation and chronic idiopathic constipation; and Namenda, which is used in the treatment of moderate to severe dementia. The company was founded in 1954 and is headquartered in New York, NY. | Health Technology |
- Beurs
- Insiders
- Howard Grossberg
- Ervaring